Related references
Note: Only part of the references are listed.Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Broadening horizons: the role of ferroptosis in cancer
Xin Chen et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2021)
mTORC1 couples cyst(e)ine availability with GPX4 protein synthesis and ferroptosis regulation
Yilei Zhang et al.
NATURE COMMUNICATIONS (2021)
Inhibition of tumor propellant glutathione peroxidase 4 induces ferroptosis in cancer cells and enhances anticancer effect of cisplatin
Xuefei Zhang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
A novel circRNA, circNUP98, a potential biomarker, acted as an oncogene via the miR-567/PRDX3 axis in renal cell carcinoma
Rui Yu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
Oncogenic activation of PI3K-AKT-mTOR signaling suppresses ferroptosis via SREBP-mediated lipogenesis
Junmei Yi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Ferroptotic damage promotes pancreatic tumorigenesis through a TMEM173/STING-dependent DNA sensor pathway
Enyong Dai et al.
NATURE COMMUNICATIONS (2020)
Role of GPX4-Mediated Ferroptosis in the Sensitivity of Triple Negative Breast Cancer Cells to Gefitinib
Xiang Song et al.
FRONTIERS IN ONCOLOGY (2020)
Ferroptosis in Neurons and Cancer Cells Is Similar But Differentially Regulated by Histone Deacetylase Inhibitors
Marietta Zille et al.
ENEURO (2019)
The ferroptosis inducer erastin irreversibly inhibits system xc- and synergizes with cisplatin to increase cisplatin's cytotoxicity in cancer cells
Mami Sato et al.
SCIENTIFIC REPORTS (2018)
Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition
Matthew J. Hangauer et al.
NATURE (2017)
Choosing the right cell line for renal cell cancer research
Klaudia K. Brodaczewska et al.
MOLECULAR CANCER (2016)
Roles of mTOR complexes in the kidney: implications for renal disease and transplantation
Daniel Fantus et al.
NATURE REVIEWS NEPHROLOGY (2016)
Erastin Disrupts Mitochondrial Permeability Transition Pore (mPTP) and Induces Apoptotic Death of Colorectal Cancer Cells
Haizhong Huo et al.
PLOS ONE (2016)
Heme oxygenase-1 accelerates erastin-induced ferroptotic cell death
Min-Young Kwon et al.
ONCOTARGET (2015)
Regulation of Ferroptotic Cancer Cell Death by GPX4
Wan Seok Yang et al.
CELL (2014)
Lipid Peroxidation and Antioxidant System in Erythrocytes of Patients with Renal Cell Carcinoma
M. N. Gerasimenko et al.
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE (2013)
mTOR Signaling in Growth Control and Disease
Mathieu Laplante et al.
CELL (2012)
Histological Subtype is an Independent Predictor of Outcome for Patients With Renal Cell Carcinoma
Bradley C. Leibovich et al.
JOURNAL OF UROLOGY (2010)
Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells
S Dolma et al.
CANCER CELL (2003)
Share Paper
